The most effective drug for Alzheimer’s has been blocked for use on the NHS. Regulators have declared the new treatment for ...

Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the ...

A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS, the ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

The U.K. watchdog declines to endorse Eli Lilly's Alzheimer's drug donanemab, citing lack of value for the NHS and ...

A wife whose husband will not be eligible for new Alzheimer’s drugs has implored health leaders to ensure that others like ...

The service screens for conditions such as Dementia, which is an umbrella term for progressive brain changes such as Alzheimer's Disease ... jointly provided by NELFT NHS Foundation Trust and the ...

Alzheimer's disease might damage the brain in two distinct phases, a new study suggests. An early phase that occurs slowly and silently appears to lay the groundwork for a second, more widely ...

Oct. 16, 2024 — Researchers used mouse models and human post-mortem brain tissue to study the molecular underpinnings that may increase the risk of Alzheimer's after ... Alzheimer's Disease May ...

MOOSIC, Pa. — Alzheimer's Disease is a brain disorder that affects the memory. Millions of people are affected in some way. "About 280,000 people in Pennsylvania are going through an Alzheimer's ...

Dr Richard Oakley, our Director of Research and Innovation, explains why Alzheimer's Society is proud to work with Our Future Health, one of the biggest health research programmes in the UK. Our ...